Port of Tauranga Limited 最大收入來源為 Port Operations,在最近的收益報告中收入為 371,898,000。就地區而言,New Zealand 是 Port of Tauranga Limited 的主要市場,收入為 416,743,000。
Waypoint Biomedical Holdings Inc 是否盈利?
是的,根據最新的財務報表,Port of Tauranga Limited 的淨利潤為 $173
Waypoint Biomedical Holdings Inc 有負債嗎?
是的,Port of Tauranga Limited 的負債為 727
Waypoint Biomedical Holdings Inc 的流通股有多少?
Port of Tauranga Limited 的總流通股為 680.25
關鍵數據
前收市價
$0.0006
開盤價
$0.0006
當日範圍
$0.0006 - $0.0006
52週區間
$0.0001 - $0.0021
交易量
9.0K
平均成交量
284
股息收益率
--
每股盈餘 (TTM)
--
市值
$33.3K
什麼是 WYPH?
WayPoint Biomedical Holdings, Inc. develops and markets an array of cutting-edge products, including their topical transdermal Health Essist Hangover-Free and Energy-Boost Power Patch lines. The company is headquartered in Huntington Beach, California. The company went IPO on 2002-11-14. The firm operates as a non-operating holding company. The company has not commenced its operations.